3,145 results on '"Jordan AS"'
Search Results
2. JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results
3. Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity
4. Clinical and functional spectrum of RAC2-related immunodeficiency
5. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation
6. Emapalumab therapy for hemophagocytic lymphohistiocytosis before reduced-intensity transplantation improves chimerism
7. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD
8. Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
9. Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
10. A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being
11. Quercetin ameliorates XIAP deficiency–associated hyperinflammation
12. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL
13. Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
14. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis
15. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation
16. Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation
17. Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma
18. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies
19. Platelets tell old red cells to clear off
20. Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma
21. Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
22. Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma
23. Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients
24. Effective Gene Therapy for Hemophilia a: Novel Re-Dosable Non-Viral Formulation That Provides Stable, and Durable FVIII Expression with Improved Tolerability
25. Biophysical Characterization of the Thermodynamic Basis and Binding Orientation for Factor VIII Membrane Association
26. Factors Associated with Prolonged CRS and Neurotoxicity after Treatment with Axicabtagene Ciloleucel
27. Comparative Efficacy of Ciltacabtagene Autoleucel Versus Elotuzumab, Isatuximab, and Selinexor-Based Regimens in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma with 1-3 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison
28. Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups
29. DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma
30. Reduced Intensity Haploidentical Bone Marrow Transplantation in Adults with Severe Sickle Cell Disease: BMT CTN 1507
31. Monoclonal gammopathy of thrombotic/thrombocytopenic significance
32. Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis
33. Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow
34. Disparities in survival by insurance status in follicular lymphoma
35. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
36. Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
37. Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
38. c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals
39. Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion
40. Low ectonucleotidase activity and increased neutrophil-platelet aggregates in patients with antiphospholipid syndrome
41. A randomized trial of blood donor iron repletion on red cell quality for transfusion and donor cognition and well-being
42. Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations
43. Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway
44. Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
45. Therapeutic targeting of acute myeloid leukemia stem cells
46. A Risk-Adapted Study to Assess the Efficacy of Enasidenib and Subsequent Response-Driven Addition of Azacitidine for Newly Diagnosed IDH2-Mutant AML Patients: 3-Year Follow-up
47. Novel Data Analytics Identify Predictors of Quality-of-Life Trajectories in Patients with AML or High-Risk Myeloid Neoplasms
48. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL
49. Monoclonal gammopathy of thrombotic/thrombocytopenic significance
50. Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.